Predicate |
Object |
contentType |
Journal Article|Meta-Analysis |
endingPage |
279 |
issn |
1523-3790 1534-6269 |
issueIdentifier |
4 |
pageRange |
272-279 |
publicationName |
Current Oncology Reports |
startingPage |
272 |
bibliographicCitation |
Gadgeel SM. The optimal chemotherapy for stage III non-small cell lung cancer patients. Curr Oncol Rep. 2011 Aug;13(4):272–9. doi: 10.1007/s11912-011-0170-3. PMID: 21479993. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_092fc7e1b07ab4864703e168c51299ef |
date |
2011-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/21479993 https://doi.org/10.1007/s11912-011-0170-3 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21927 https://portal.issn.org/resource/ISSN/1534-6269 https://portal.issn.org/resource/ISSN/1523-3790 |
language |
English |
source |
https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
The Optimal Chemotherapy for Stage III Non–Small Cell Lung Cancer Patients |
discusses |
http://id.nlm.nih.gov/mesh/M0001483 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D002289Q000628 http://id.nlm.nih.gov/mesh/D008175Q000628 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D002986 http://id.nlm.nih.gov/mesh/D059248 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D009367 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID426756 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8911 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9710 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7655 |